<DOC>
	<DOCNO>NCT01692041</DOCNO>
	<brief_summary>The trial aim record possible effect supplementary treatment ivy leave dry extract different lung function parameter , bronchial hyperreactivity , individual marker asthmatic inflammation clinical symptom profile . The hypothesis , additional therapy might improve parameter might help optimize asthma therapy .</brief_summary>
	<brief_title>Effect add-on Treatment With Ivy Leaves Dry Extract Lung Function Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Medical diagnosis uncontrolled , mild , persistent , allergic bronchial asthma term bronchial asthma NVL Version 1.3 ( 2011 ) 2 . Children age 6 12 year ( girl boys ) 3 . Signed Informed Consent patient legal guardian participate trial write verbal briefing Investigator 4 . Improvement FEV1≥12 % 2 puff terbutaline 100 µg steroid monotherapy 400 µg budesonide equivalent/day ACT score ≤ 19 indication insufficient asthma control 5 . Asthma diagnosis least 1 year 1 . Anamnestically know intolerance/allergy one drug apply ingredient drug similar chemical structure 2 . Participation patient another clinical trial within last four week enrollment trial 3 . Evidence suggest patient legal representative likely follow trial protocol ( e.g . lack compliance ) 4 . Inability measure lung function , test bronchospasmolysis , determine FeNO collect exhale breath condensate , inability document symptom symptom log book questionnaire ; inability take trial medication properly 5 . Chronic illness different aetiology 6 . Vocal cord dysfunction 7 . Premature birth diagnosis bronchopulmonary dysplasia 8 . Gastroesophageal reflux 9 . Acute respiratory infection within previous 4 week 10 . Hereditary fructose intolerance 11 . Pregnant breastfeeding girl</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>child</keyword>
</DOC>